Antihemostatic Therapy and Endoscopic Biliary Sphincterotomy Induced Bleeding

Yuksek Ihtisas Hospital350 enrolled

Overview

The aim of the study is to observe the effects of antihemostatic therapy including nonsteroidal antiinflammatory, anticoagulant and antiaggregant therapy and other patient and procedure related factors on the risk of endoscopic biliary sphincterotomy induced bleeding.

Study Type

OBSERVATIONAL

Enrollment

350

Conditions

Endoscopic Biliary Sphincterotomy Bleeding

Eligibility

Sex: ALLMin age: 17 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Hospitalization * Endoscopic sphincterotomy * The patients whose warfarin treatment was stopped and INR was normalized prior to examination Exclusion Criteria: * The patients who had undergone endoscopic cholangiography with no sphincterotomy * Outpatient procedures

Locations (1)

Turkiye Yuksek Ihtisas Hospital

Ankara, Turkey (Türkiye)

RECRUITING

Outcomes

Primary Outcomes

Bleeding induced by endoscopic biliary sphincterotomy

Time frame: 3 months

Central Contacts

Ibrahim Koral Onal, MD

CONTACT

903123061334 koralonal@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.